CLINICAL AND PROGNOSTIC VALUE OF HYPONATREMIA IN PATIENTS WITH CHRONIC HEART FAILURE

The aim: to assess the short-term prognostic value of different types of hyponatremia in patients hospitalized for acute decompensated chronic heart failure. Material and methods. A prospective study included 396 patients hospitalized for acute decompensated chronic heart failure. Hyponatremia was diagnosed in cases of serum sodium level less than 135 mmol/l. The pre-hospital hyponatremia was defined as a decreased serum sodium level on admission, whereas the hospital hyponatremia was referred to cases occurred during hospitalization. In patients with pre-hospital hyponatremia drop of sodium levels ≥ 3 mmol/l during hospitalization was defined as a progressive hyponatraemia. The influence of different types of hyponatremia on the hospital prognosis was determined, while the composite primary endpoint was all-cause mortality and/or transfer to the intensive care unit. Results. Patients with hyponatremia were older and had more severe clinical signs of chronic heart failure, lower left ventricle ejection fraction and higher diastolic dysfunction than normonatremic patients. After adjustment for age, comorbidity and severity of chronic heart failure in Cox regression models hyponatremia was an independent predictor of all-cause mortality and transfer to the intensive care unit (odds ratio 3.1; p < 0.05). Pre-hospital hyponatremia had a higher prognostic value on outcome compared with hospital hyponartemia  (odds ratio 3.9 versus 2.9, respectively; p < 0.05). Progressive hyponatremia was associated with a marked increase of mortality and transfer to the intensive care unit (odds ratio 6.8; p < 0.05). Conclusion. Pre-hospital and hospital hyponatremia are independent predictors for short-term outcomes in patients hospitalized for acute decompensated chronic heart failure. Progression of the pre-hospital hyponatremia is associated with significantly increase of all-cause mortality and risk of transfer to the intensive care unit.

hyponatremia, chronic heart failure, decompensation, severity of the disease, prognosis, mortality

1. Deitelzweig S.B., McCormick L. Hyponatremia in hospitalized patients: the potential role of tolvaptan. Hosp Pract (1995). 2011; 39(3): 87-98.

2. Braun M.M., Barstow C.H., Bragg F. et al. Diagnosis and Management of Sodium Disorders: Hyponatremia and Hypernatremia Am Fam Physician. 2015; 91(5): 299-307.

3. Holland-Bill L. Hyponatraemia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. European Journal of Endocrinology. 2015; 173(1): 71-81.

4. Callahan M.A., Do H.T., Caplan D.W. et al. Economic impact of hyponatremia in hospitalized patients: a retrospective cohort study. Postgrad Med. 2009; 121(2): 186-91.

5. Zilberberg M.D., Exuzides A., Spalding J. et al. Epidemiology, clinical and economic outcomes of hyponatremia in a cohort of hospitalized patients. Curr Med Res Opin. 2008; 24: 1601-8.

6. Waikar S.S., Mount D.B., Curhan G.C. Mortality after hospitalization with mild, moderate, and severe hyponatremia. American Journal of Medicine. 2009: 122857-865.

7. Sturdik I., Adamcova M., Kollerova J. et al. Hyponatraemia is an independent predictor of in-hospital mortality. European Journal of Internal Medicine. 2014; 25: 379-382.

8. Frenkel W.N., van den Born B.J., van Munster B.C. et al. The association between serum sodium levels at time of admission and mortality and morbidity in acutely admitted elderly patients: a prospective cohort study. Journal of the American Geriatrics Society. 2010; 5: 2227-2228.

9. Schekochihin D.Y. Prognostic value of prehospital and intrahospital hyponatremia in decompensation of chronic heart failure. Rational pharmacotherapy in cardiology. 2014; 10(6): 640. [In Russian].

10. Oren R.M. Hyponatremia in congestive heart failure. Am J Cardiol. 2005; 2:95(9A): 2B-7B.

11. Filippatos G., Rossi J., Lloyd-Jones D.M. et al. Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study. J Card Fail. 2007; 13: 360-364.

12. Gheorghiade M., Rossi J.S., Cotts W. et al. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE trial. Archives of Internal Medicine. 2007; 167(18): 1998-2005.

13. Klein L., O’Connor C.M., Leimberger J.D. et al. Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure (OPTIME-CHF) study. Circulation. 2005; 111(19): 24542460.

14. Spasovski G., Vanholder R., Allolio B. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014; 40 (6): 924.

15. Hillier T.A., Abbott R.D., Barrett E.J. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med. 1999; 106 (4): 399-403.

16. Kishkun A.A. Clinical laboratory diagnostics: a training manual. 2015; 458 с. [In Russian].

17. Ponikowski P., Voors A.A., Anker D.S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). EHJ. 2016; 37 (27): 2129-2200.

18. Mancia G., Fagard R., Narkiewicz K. и др. ESH / ESC Рекомендации по лечению артериальной гипертонии. Российский кардиологический журнал. 2014; 1 (105): 7-94 Mancia G., Fagard R., Narkiewicz K. et al. ESH/ESC guidelines for treatment of arterial hypertension. Russian journal of cardiology. 2014; 1 (105): 7-94. [In Russian].

19. Montalescot G., Sechtem U., Achenbach S. и др. Рекомендации ESC по лечению стабильной ишемической болезни сердца. Российский кардиологический журнал. 2014; 7 (111): 7-79 Montalescot G., Sechtem U., Achenbach S. et al. ESC guidelines for treatment of stable coronary artery disease. Russian journal of cardiology. 2014; 7 (111): 7-79. [In Russian].

20. Mareev V.Y., Ageev F.T., Arutyunov G.P. National recommendations of OSSN, RKO and RNMOT on diagnosis and treatment of CHF (fourth revision). Journal of Heart Failure. 2013; 14 (7). [In Russian].

21. P. Ponikowski, A.A. Voors, S.D. Anker и др. ESC рекомендации по диагностике и лечению острой и хронической сердечной недостаточности. Российский кардиологический журнал. 2017; 1 (141): 7–81. P. Ponikowski, A.A. Voors, S.D. Anker et al. ESC guidelines on the diagnosis and treatment of acute and chronic heart failure 2016. Russian journal of cardiology. 2017; 1 (141): 7–81. [In Russian].

22. J.G. Verbalis, S.R. Goldsmith, A. Greenberg et al. Hyponatremia Treatment Guidelines 2007: Expert Panel Recommendations. The American Journal of Medicine. 2007; 120 (11A), S15–S7.

23. Verbrugge F.H., Steels P., Grieten L. et al. Hyponatremia in Acute Decompensated Heart Failure Depletion Versus Dilution. Journal of the American College of Cardiology. 2015; 24. Adrogué H.J. Hyponatremia in Heart Failure. Cardiovasc J. 2017; 13 (1): 40.